The TRIUMPH study (TRanslational Initiative on Unique and novel strategies for Management of Patients with Heart failure) showed that NT-proBNP and comorbidities (COPD, anxiety, depression, HTN) are the main determinants of the quality of life in patients with AHF [48]. This evidence concerns the gene NPPB and depressive disorder.